Science Explorer Back to mapMap
Discussion
Topic · Pulmonary and Respiratory Medicine

Vasculitis and related conditions

Vasculitis and related conditions is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 26k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the classification, diagnosis, and management of various vasculitides, including ANCA-associated vasculitis, giant cell arteritis, polyarteritis nodosa, Churg-Strauss syndrome, and Takayasu arteritis. It discusses the use of rituximab and other therapies, as well as EULAR recommendations for the management of vasculitis. Additionally, it explores the role of imaging in diagnosing and monitoring vasculitic diseases.

  • Vasculitides
  • ANCA-associated
  • Giant Cell Arteritis
  • Polyarteritis Nodosa
  • Churg-Strauss Syndrome
  • Takayasu Arteritis
  • Rituximab
  • EULAR Recommendations
  • Glomerulonephritis
  • Imaging in Vasculitis
Research works
26k
fractional, since 1950
In the world top 10%
2.7k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+18%
the tick is no change
Largest producer
United States
27% of the 10 largest, 2022-now
Vasculitis and related conditions

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Vasculitis and related conditions research?

By volume, the United States and China publish the most (1.2k and 787 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.2k works
  2. 2 China 787 works
  3. 3 Japan 523 works
  4. 4 India 378 works
  5. 5 United Kingdom 325 works
  6. 6 France 275 works
  7. 7 Germany 241 works
  8. 8 Italy 238 works
  9. 9 Spain 231 works
  10. 10 Türkiye 226 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 26.5%China: 17.9%Japan: 11.9%India: 8.6%6 others listed: 35.0%27%largest
United States1,165 · 26.5%China787 · 17.9%Japan523 · 11.9%India378 · 8.6%6 others listed1,537 · 35.0%

Shares of the rows listed above, not of the whole node.

Which institutions lead Vasculitis and related conditions research?

By volume in 2022-now, Mayo Clinic publishes the most Vasculitis and related conditions research, followed by Capital Medical University and Harvard University.

By volume, 2022-now

  1. 1 Mayo ClinicUnited States 65 works
  2. 2 Capital Medical UniversityChina 47 works
  3. 3 Harvard UniversityUnited States 45 works
  4. 4 All India Institute of Medical SciencesIndia 37 works
  5. 5 Université Paris CitéFrance 35 works
  6. 6 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 33 works
  7. 7 Peking UniversityChina 32 works
  8. 8 InsermFrance 32 works
  9. 9 Yonsei UniversitySouth Korea 32 works
  10. 10 Tsinghua UniversityChina 25 works

Who are the leading researchers in Vasculitis and related conditions?

The most-cited researchers publishing on Vasculitis and related conditions include Jost Bruno Jonas, Jun Wang and Giuseppe Remuzzi.

  1. 1 Jost Bruno Jonas Germany 350k citations
  2. 2 Jun Wang China 340k citations
  3. 3 Giuseppe Remuzzi Italy 328k citations
  4. 4 Gordon Henry Guyatt Canada 315k citations
  5. 5 Gregory Y.H. Lip United Kingdom 311k citations
  6. 6 Hagop M. Kantarjian United States 273k citations
  7. 7 Marcello A. Tonelli Canada 268k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Vasculitis and related conditions?

The most cited paper in Vasculitis and related conditions is "2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides" (J. Charles Jennette et al., 2012), with 6,681 citations. Next come "Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II" (5,546) and "Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach" (4,380).

Most cited papers
#PaperReleasedCitations
1 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides J. Charles Jennette et al. · Arthritis & Rheumatism Open access 8 Oct 2012 6,681
2 Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II Reva C. Lawrence, David T. Felson, Charles G. Helmick et al. · Arthritis & Rheumatism Open access 28 Dec 2007 5,546
3 Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach Lee A. Hebert, Samir M. Parikh, Jason M. Prosek et al. · American Journal of Nephrology Open access 2013 4,380
4 Nomenclature of Systemic Vasculitides J. Charles Jennette, Ronald J. Falk, K. Andrássy et al. · Arthritis & Rheumatism Feb 1994 3,862
5 Wegener Granulomatosis: An Analysis of 158 Patients Gary Stuart Hoffman, Gail S. Kerr, Randi Y. Leavitt et al. · Annals of Internal Medicine 15 Mar 1992 2,881
All 98 most cited papers, with filters and sorting

Where is Vasculitis and related conditions research done?

The largest centres of Vasculitis and related conditions research in 2022-now are Beijing (China), Tokyo (Japan), Paris (France) and Istanbul (Türkiye). Among places with at least 20 works in it, it is an unusually large share of all research in Rochester.

Largest cities, 2022-now

  1. 1 BeijingChina 176 works
  2. 2 TokyoJapan 131 works
  3. 3 ParisFrance 113 works
  4. 4 IstanbulTürkiye 81 works
  5. 5 LondonUnited Kingdom 76 works
  6. 6 MadridSpain 67 works
  7. 7 SeoulSouth Korea 63 works
  8. 8 ShanghaiChina 60 works
  9. 9 AnkaraTürkiye 56 works
  10. 10 São PauloBrazil 50 works

Where it is the local speciality

  1. RochesterUS · 21.7 works8.8×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Vasculitis and related conditions than the world average.

See Vasculitis and related conditions on the map

Where is the best place to study Vasculitis and related conditions?

Among universities, judged by research, University of Groningen, Capital Medical University and Peking University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 20.75%fractional works in this field (log) →share of work in the world top 10% →University of Gronin…Peking UniversityHarvard UniversityCapital Medical Univ…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1University of GroningenNetherlands 67.839.3%4.9×18 -37.2%
2Capital Medical UniversityChina 58.88.1%8.2×47 +78.8%
3Peking UniversityChina 58.216.3%2.9×32 +10.0%
4Harvard UniversityUnited States 58.013.2%2.6×45 -9.4%
5Universität HamburgGermany 57.424.1%4.1×16 +22.8%
6Université Paris CitéFrance 56.414.3%8.6×35 -25.8%
7Johns Hopkins UniversityUnited States 55.516.7%2.7×23 +18.6%
8Aarhus UniversityDenmark 55.439.7%1.9×9 +9.3%
9Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 55.015.1%5.7×33 +11.0%
10Universitat de BarcelonaSpain 54.520.7%4.2×17 +14.9%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Vasculitis and related conditions, country by country

Is Vasculitis and related conditions research growing?

Output in 2022-2025 was 18% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Vasculitis and related conditions.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Vasculitis and related conditions as a percentage of every work published that year, 0.024% in 2024.

still counting0.020%0.040%Vasculitis and related conditions0.027% in 202519801990200020102020

Fractional works of Vasculitis and related conditions over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Vasculitis and related conditions10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Vasculitis and related conditions. Posts are plain text and can be reported.